Bpom Kelly 2020: What You Need To Know

Posted on
2020_2 kelly
2020_2 kelly from kellyahopkins.com

The Role of BPOM in Indonesia

The Indonesian National Agency of Drug and Food Control, or Badan Pengawas Obat dan Makanan (BPOM), is responsible for ensuring the safety, efficacy, and quality of food, drugs, and cosmetics in the country. BPOM works closely with local and international organizations to prevent the circulation of illegal or harmful products in the market.

Introduction to BPOM Kelly

In 2020, BPOM appointed a new head, Penny K. Lukito, or commonly known as BPOM Kelly. With her extensive experience in public health and regulatory affairs, BPOM Kelly aimed to improve the agency’s efficiency and transparency in fulfilling its mandate.

BPOM Kelly’s Priorities

One of BPOM Kelly’s main priorities was to strengthen the agency’s risk-based approach to regulatory decision-making. This means that BPOM would prioritize products with higher risks of harm to consumers and allocate resources accordingly. BPOM Kelly also emphasized the importance of data-driven decision-making to ensure that regulatory actions are based on scientific evidence.

BPOM Kelly’s Achievements in 2020

Under BPOM Kelly’s leadership, BPOM made significant progress in improving its regulatory framework. The agency implemented a new electronic registration system for food and drug products, which streamlined the registration process and reduced the time required for approval. BPOM also strengthened its post-marketing surveillance system to monitor the safety and quality of products already on the market.

Challenges Faced by BPOM Kelly

Despite these achievements, BPOM Kelly faced several challenges in 2020. One of the most significant was the COVID-19 pandemic, which put additional pressure on BPOM to expedite the approval of drugs and medical devices to treat the disease. BPOM Kelly also had to navigate the complex regulatory landscape of the Indonesian market, which is known for its high levels of corruption and bureaucracy.

BPOM Kelly’s Response to the COVID-19 Pandemic

In response to the pandemic, BPOM Kelly implemented several measures to ensure the availability of safe and effective medical products. The agency prioritized the registration of COVID-19 test kits, drugs, and vaccines, and set up a dedicated task force to expedite the approval process. BPOM Kelly also collaborated with international regulatory agencies to share data and best practices.

Future Directions for BPOM Kelly

Looking ahead, BPOM Kelly has outlined several key priorities for the agency in the coming years. These include strengthening the agency’s capacity to regulate emerging technologies such as gene therapy and artificial intelligence, as well as improving its communication and engagement with stakeholders. BPOM Kelly also plans to continue building partnerships with local and international organizations to enhance regulatory harmonization and information sharing.


In conclusion, BPOM Kelly’s leadership has brought significant improvements to Indonesia’s regulatory landscape in 2020. Despite facing numerous challenges, BPOM Kelly has demonstrated her commitment to ensuring the safety and quality of food, drugs, and cosmetics for Indonesian consumers. With her vision for the future, BPOM is well-positioned to continue its important work in protecting public health and safety.

Leave a Reply

Your email address will not be published. Required fields are marked *